Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

137 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Spicing things up: synthetic cannabinoids.
Spaderna M, Addy PH, D'Souza DC. Spaderna M, et al. Psychopharmacology (Berl). 2013 Aug;228(4):525-40. doi: 10.1007/s00213-013-3188-4. Epub 2013 Jul 9. Psychopharmacology (Berl). 2013. PMID: 23836028 Free PMC article. Review.
Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.
Krystal JH, Karper LP, Bennett A, D'Souza DC, Abi-Dargham A, Morrissey K, Abi-Saab D, Bremner JD, Bowers MB Jr, Suckow RF, Stetson P, Heninger GR, Charney DS. Krystal JH, et al. Psychopharmacology (Berl). 1998 Feb;135(3):213-29. doi: 10.1007/s002130050503. Psychopharmacology (Berl). 1998. PMID: 9498724 Clinical Trial.
Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.
Krystal JH, D'Souza DC, Karper LP, Bennett A, Abi-Dargham A, Abi-Saab D, Cassello K, Bowers MB Jr, Vegso S, Heninger GR, Charney DS. Krystal JH, et al. Psychopharmacology (Berl). 1999 Jul;145(2):193-204. doi: 10.1007/s002130051049. Psychopharmacology (Berl). 1999. PMID: 10463321 Clinical Trial.
Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
Abi-Saab W, Seibyl JP, D'Souza DC, Karper LP, Gueorgueva R, Abi-Dargham A, Wong ML, Rajhans S, Erdos JP, Heninger GR, Charney DS, Krystal JH. Abi-Saab W, et al. Psychopharmacology (Berl). 2002 Jun;162(1):55-62. doi: 10.1007/s00213-002-1057-7. Epub 2002 Apr 5. Psychopharmacology (Berl). 2002. PMID: 12107618 Clinical Trial.
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
Krystal JH, Abi-Saab W, Perry E, D'Souza DC, Liu N, Gueorguieva R, McDougall L, Hunsberger T, Belger A, Levine L, Breier A. Krystal JH, et al. Psychopharmacology (Berl). 2005 Apr;179(1):303-9. doi: 10.1007/s00213-004-1982-8. Epub 2004 Aug 10. Psychopharmacology (Berl). 2005. PMID: 15309376 Clinical Trial.
Greater vulnerability to the amnestic effects of ketamine in males.
Morgan CJ, Perry EB, Cho HS, Krystal JH, D'Souza DC. Morgan CJ, et al. Psychopharmacology (Berl). 2006 Sep;187(4):405-14. doi: 10.1007/s00213-006-0409-0. Epub 2006 Aug 1. Psychopharmacology (Berl). 2006. PMID: 16896964 Clinical Trial.
137 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page